L-TIL in Patients With Malignancy Resistance to Anti-PD-1 Therapy

NCT04268108 · clinicaltrials.gov ↗

UNKNOWN

Status

30

Enrollment

OTHER_GOV

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

BIOLOGICAL: liquid tumor infiltrating lymphocytes

Sponsor

Henan Cancer Hospital